Docoh
Loading...

TOMDF Todos Medical

Press releases

From Benzinga Pro
Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation
2 Dec 21
Press Releases
Dr. Jules Mitchel now leading preparation for data lock and statistical analysisBusiness update call Today at 4:30PM EST New York, NY, and Tel Aviv, ISRAEL, Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos
Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST
1 Dec 21
Press Releases
New York, NY, and Tel Aviv, ISRAEL, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical Confirms SARS-CoV-2 PCR Test Kits Used at CLIA/CAP Lab Provista Diagnostics Detect Omicron Variant
30 Nov 21
Press Releases
Provista to also utilize Osang's High-Capacity Reflex Variant PCR Detection Kit that has been confirmed to identify the Omicron variant New York, NY, and Tel Aviv, ISRAEL, Nov. 30, 2021 (GLOBE NEWSWIRE) --
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
29 Nov 21
M&A, News, Press Releases
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IP Dr. Dorit Arad,
Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece
22 Nov 21
Press Releases, General
· T-Cell Protect is also evaluating expected demand for maximum strength Tollovid® New York, NY, and Tel Aviv, ISRAEL, Nov. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd.
Dietary Supplements Become a Mainstay for Those Seeking a Healthier Lifestyle
19 Nov 21
Small Cap, Opinion, Press Releases
NEW YORK, Nov. 19, 2021 /PRNewswire/ -- Dietary supplement products are now part of a rapidly growing market. The growth in demand for such products can be attributed in part to rising health and fitness concerns. In
Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients
19 Nov 21
Press Releases
Enrollment now paused in the randomized, double blind, placebo controlled clinical trial in severe and critical hospitalized COVID-19 patients to complete interim analysisData from the interim analysis expected in
Todos Medical Announces Addition of Semi-Quantitative Titer Claims to the Emergency Use Authorization for the cPass Neutralizing Antibody Test
17 Nov 21
Press Releases
· Reauthorization of EUA expands beyond initial qualitative detection claim · CEO to appear on Cheddar News at 6:10pm tonight, November 17th, 2021 New York, NY, and Tel Aviv, ISRAEL, Nov. 17,
Update: Todos Medical Reports Third Quarter 2021 Business and Financial Results
16 Nov 21
Earnings, Press Releases
New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company,
Todos Medical's Provista Laboratory to Boost Top Line Through New Atlanta-based Reference Lab Agreement for COVID PCR, cPass Neutralizing Antibody & Respiratory Pathogen Panel Tests
16 Nov 21
Press Releases, General
New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical Reports Third Quarter 2021 Business and Financial Results
15 Nov 21
Earnings, Press Releases
New York, NY, and Tel Aviv, ISRAEL, Nov. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company,
Todos Medical Sees Significant Ramp Up in COVID PCR Testing Volume at Its Provista CLIA/CAP Lab with New Automation in Place
2 Nov 21
Press Releases, General
Automation enabled Provista to conduct over 7,600 PCR tests for the month of October, more than in the first 8 months of 2021 combinedCompany sees expanding testing for COVID PCR, neutralizing antibody and flu
Todos Medical Announces 2nd Clinical Trial Site for Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
1 Nov 21
Press Releases
§ Interim Clinical Trial Data from Phase 2 expected in Q4/21 § Nature Neuroscience and Cell Reports publications highlight 3CLpro (Mpro)'s complementary mechanisms of virus replication and immune suppression
Todos Medical to Present at the Benzinga Global Small Cap Conference
26 Oct 21
Press Releases
New York, NY, and Tel Aviv, ISRAEL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical Announces Publication in Nature Neuroscience That Describes the Main Protease (3CL Protease) Causes Microvascular Brain Pathology
25 Oct 21
Press Releases
New York, NY, and Tel Aviv, ISRAEL, Oct. 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical Announces Publication in Journal of Clinical Virology Highlighting Clinical Utility of cPass Semi-Quantitative Neutralizing Antibody Test in SARS-CoV-2 Risk Assessment Post-Vaccination or Recovery from Infection
21 Oct 21
Press Releases
Company hosting cPass webinar on Friday, October 22, 2021 for long-term care facilities New York, NY, and Tel Aviv, ISRAEL, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos
Todos Medical to Conduct Webinar Highlighting the cPass SARS-COV-2 Neutralizing Antibody Test for AMDA, The Society for Post-Acute and Long-Term Care Medicine, on October 22, 2021 at 12:00 PM EDT
14 Oct 21
Press Releases
Dr. Jorge Leone, Chief Scientific Officer of Todos Medical, and Sean Taylor, North American FAS Manager of Genscript, will discuss the importance of the cPass™ SARS-COV-2 neutralizing antibody test as a "New
Todos Medical Announces Positive Data in Hospitalized and Outpatient Setting for TolloTest™, a Novel SARS-CoV-2 3CL Protease Biomarker Assay
6 Oct 21
Press Releases, General
Data demonstrated very high correlation with PCR ct values in positive patients Data demonstrated 100% sensitivity, as early as 1-3 days post-exposure, in identifying fully vaccinated asymptomatic patients infected with
UPDATE - Todos Medical Announces October Conference Calendar
5 Oct 21
Health Care, Press Releases
NEW YORK, NY and Tel Aviv, ISRAEL, Oct. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical Provides Update on COVID-19 Oral Antiviral 3CL Protease (Main Protease) Inhibitor Tollovir Clinical Development Program in Light of Molnupiravir Clinical Trial Data from Merck
4 Oct 21
Press Releases
New York, NY, and Tel Aviv, ISRAEL, Oct. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. ("Todos Medical") (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today